Endovascular Thrombectomy Versus Bridging Thrombolysis: Real-World Efficacy and Safety Analysis Based on a Nationwide Registry Study.

Chang Geng,Sheng‐De Li,Ding‐Ding Zhang,Lin Ma,Guo‐Wei Liu,Li‐Qun Jiao,Jian‐Min Liu,Wen‐Huo Chen,Wu‐Sheng Zhu,Chang‐Ming Wen,Bin Peng
DOI: https://doi.org/10.1161/jaha.120.018003
IF: 6.106
2021-01-28
Journal of the American Heart Association
Abstract:Background It was uncertain if direct endovascular thrombectomy (ET) was superior to bridging thrombolysis (BT) for patients with acute ischemic stroke caused by large‐vessel occlusions. We aimed to examine real‐world clinical outcomes of ET using nationwide registry data in China and to compare the efficacy and safety between BT and direct ET. Methods and Results Patients treated with ET from a nationwide registry study in China were included. Rapid neurological improvement, intracranial hemorrhage, and in‐hospital mortality were compared between the 2 groups using multivariate logistic models and propensity‐score matching analyses. A total of 7674 patients from 592 stroke centers were included. The median onset‐to‐puncture time, onset‐to‐door time, and door to puncture time were 290, 170, and 99 minutes, respectively. A total of 2069 (27.0%) patients received BT treatment. Patients in the BT group had a significantly shorter onset‐to‐puncture time (235 versus 323 minutes; P <0.001) and onset‐to‐door time (90 versus 222 minutes; P <0.001) compared with the direct ET group. The prior use of intravenous thrombolysis was associated with a higher rate of rapid neurological improvement (adjusted odds ratio [OR], 0.83; 95% CI, 0.71–0.96) and higher risk of intracranial hemorrhage (adjusted OR, 1.46; 95% CI, 1.18–1.80) in multivariate analyses and propensity‐score matching analyses. Conclusions This study reflects the current application of ET in China. More patients received direct ET than BT. Our results suggested that favorable short‐term outcomes could be achieved with BT compared with direct ET. Higher risk of intracranial hemorrhage was observed in the BT group. Nonstandard Abbreviations and Acronyms AIS acute ischemic stroke BOSC Bigdata Observatory Platform for Stroke of China BT bridging thrombolysis CSPPC‐DEBATE China Stroke Prevention Project Committee–Direct Endovascular Thrombectomy and Bridging Thrombolysis DIRECT‐MT Direct Intraarterial Thrombectomy in Order to Revascularize Acute Ischemic Stroke Patients with Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals: a Multicenter Randomized Clinical Trial DPT door‐to‐puncture time ET endovascular thrombectomy ICH intracranial hemorrhage IVT intravenous thrombolysis NIHSS National Institutes of Health Stroke Scale OPT onset‐to‐puncture time PSM propensity‐score matching RNI rapid neurological improvement TOAST Trial of Org 10172 in Acute Stroke Treatment Clinical Perspective What Is New? Nationwide real‐world data on the clinical application and outcomes of endovascular thrombectomy (ET) in China were provided in the study. Comparison of clinical outcomes of patients treated with bridging thrombolysis (BT) and direct ET in daily practice was performed in the study. A total of 27.0% patients in the study received BT, and the main reason for patients who received direct ET without intravenous thrombolysis was beyond time window; short‐term favorable outcomes in BT‐treated patients were achieved compared with direct ET, although a higher risk of intracranial hemorrhage was observed in the BT group. What Are the Clinical Implications? A more efficient stroke management workflow in stroke units in China is indispensable to reduce prehospital delay, which may increase BT rates and improve functional outcomes. Our results support present guidelines that patients treated with BT have more favorable outcomes. <p class="inlin -Abstract Truncated-
cardiac & cardiovascular systems
What problem does this paper attempt to address?